NCT06015607
Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the Colon
Recruiting
NAAges 21+InterventionalTreatmentActuated Medical, Inc.
~30 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Control (via ESD using standard of care)GripTract
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Total Number of Device-Attributable Major Adverse Events
Measured over Enrollment to 30 days
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesOhio1
Study leadership
- Emre Gorgun, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients scheduled for endoscopic removal of suspected adenomatous benign polyps(s)
Patients capable of giving informed consent English and lacking cognitive impairment
No medical contraindication to endoscopic mucosal resection or endoscopic submucosal dissection
Exclusion
Patients less than 21 years of age
Any contraindication to colonoscopy with due to subject's colon anatomy (i.e., structure)
History of open or laparoscopic colorectal surgery
History of Inflammatory Bowel Disease
Patients requiring multiple polyp removals
What this trial measures
- Total Number of Device-Attributable Major Adverse EventsEnrollment to 30 days
Subjects will receive follow-ups at 24 hrs, 72 hours, and 30 days post intervention to monitor adverse events. Major adverse events are those that necessitate non-endoscopic intervention.
- Total Number of Device-Attributable Minor Adverse EventsEnrollment to 30 days
Subjects will receive follow-ups at 24 hrs, 72 hrs, and 30 days post intervention to monitor adverse events. Minor adverse events are those that can be successfully addressed endoscopically.